Compare Avalanche Treasury Corporation Class A Common Stock (AVAT) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Avalanche Treasury Corporation Class A Common Stock vs Smith & Nephew plc — how do they compare? Avalanche Treasury Corporation Class A Common Stock trades at $0.35 (market cap $15.33M), while Smith & Nephew plc trades at $29.8 (market cap $12.54B). The key difference: Smith & Nephew plc is far larger — about 818× Avalanche Treasury Corporation Class A Common Stock's market cap, and Smith & Nephew plc pays a 2.65% dividend while Avalanche Treasury Corporation Class A Common Stock pays none. Which is the better fit depends on your goals.
| AVAT | SNN | |
|---|---|---|
Market Cap | $15.33M | $12.54B |
Sector | Financials | Health |
52-Week High | $10.75 | $38.70 |
52-Week Low | $0.30 | $28.73 |
Enterprise Value | $15.33M | $15.57B |
Dividend Yield | — | 2.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AVAT trades at $0.37, up 9.83% in the past 24 hours. The stock shows a bearish technical signal with negative cash flow from operations of -$930,710 in 2025, though net income is positive at $8.28 million. Recent news highlights its Nasdaq listing as an operating company focused on capital allocation.
The outlook is cautious due to weak operational cash flow and bearish technical indicators. Investment appeal hinges on improved profitability and cash generation. Key risks include execution challenges and market volatility.
Smith & Nephew (SNN) trades at $29.76, down 1.06% with bearish technical signals. The company shows improving fundamentals with revenue growth from $5.8B to $6.2B and net income margin expanding to 10.08% in 2025. Recent Q2 2026 earnings beat expectations but the company lowered full-year revenue guidance from 6% to 4% growth due to U.S. Orthopaedics weakness.
While valuation multiples appear reasonable (P/E 20.41, EV/EBITDA 9.9), the stock faces headwinds from mixed earnings performance and cautious analyst sentiment. The primary investment case hinges on execution in robotics and wound care segments offsetting orthopedic challenges, with downside risk from continued U.S. market softness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Avalanche Treasury Corporation Class A Common Stock
Avalanche Treasury Corp operates as a digital asset treasury company focused on holding and managing digital asset investments. The company was founded on September 22, 2025, and is headquartered in New York, NY.
Read more on AVAT →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
